Nutriband (NTRB) Competitors

Nutriband (NASDAQ:NTRB) and Nevro (NYSE:NVRO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

Which has higher valuation and earnings, NTRB or NVRO?

Nutriband has higher earnings, but lower revenue than Nevro. Nutriband is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutriband	$2.02M	34.61	-$5.49M	-$0.99	-6.36
Nevro	$408.52M	0.55	-$92.21M	-$3.05	-1.92

Do institutionals and insiders believe in NTRB or NVRO?

19.7% of Nutriband shares are held by institutional investors. Comparatively, 95.5% of Nevro shares are held by institutional investors. 54.1% of Nutriband shares are held by company insiders. Comparatively, 3.2% of Nevro shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Is NTRB or NVRO more profitable?

Nevro has a net margin of -16.54% compared to Nutriband's net margin of -338.51%. Nevro's return on equity of -23.52% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutriband	-338.51%	-54.49%	-48.52%
Nevro	-16.54%	-23.52%	-10.83%

Do analysts prefer NTRB or NVRO?

Nutriband currently has a consensus price target of $13.00, suggesting a potential upside of 106.35%. Nevro has a consensus price target of $5.36, suggesting a potential downside of 8.29%. Given Nutriband's stronger consensus rating and higher probable upside, equities research analysts plainly believe Nutriband is more favorable than Nevro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutriband	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Nevro	2 Sell rating(s)	9 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.92

Does the MarketBeat Community favor NTRB or NVRO?

Nevro received 500 more outperform votes than Nutriband when rated by MarketBeat users. Likewise, 62.22% of users gave Nevro an outperform vote while only 44.44% of users gave Nutriband an outperform vote.

Company	Underperform	Outperform
Nutriband	Outperform Votes 4 44.44%	Underperform Votes 5 55.56%
Nevro	Outperform Votes 504 62.22%	Underperform Votes 306 37.78%

Which has more risk and volatility, NTRB or NVRO?

Nutriband has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, Nevro has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500.

Does the media refer more to NTRB or NVRO?

In the previous week, Nutriband had 6 more articles in the media than Nevro. MarketBeat recorded 7 mentions for Nutriband and 1 mentions for Nevro. Nevro's average media sentiment score of 0.00 beat Nutriband's score of -0.34 indicating that Nevro is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutriband	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Nevro	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Nevro beats Nutriband on 9 of the 17 factors compared between the two stocks.